Importance of eliminating potential dental focal infection before the first cycle of chemotherapy in patients with hematologic malignancy

Affiliations

• ¹ Department of Oral and Maxillofacial Surgery, Center Hospital of the National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan. yasuyuki.shimada.ys@gmail.com.
• ² Department of Drug Evaluation and Informatics, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan. yasuyuki.shimada.ys@gmail.com.
• ³ AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
• ⁴ Department of Drug Evaluation and Informatics, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
• ⁵ Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan.
• ⁶ Center for the Promotion of Interdisciplinary Education and Research (C-PIER), Kyoto University, Kyoto, Japan.
• ⁷ Keihanshin Consortium for Fostering the Next Generation of Global Leaders in Research (K-CONNEX), Kyoto, Japan.
• ⁸ Division of Hematology, Department of Internal Medicine, Center Hospital of the National Medical Center for Global Health and Medicine, Tokyo, Japan.
• ⁹ Department of Oral and Maxillofacial Surgery, Center Hospital of the National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan.
• ¹⁰ Oral and Maxillofacial Surgery, Department of Oral Restitution, Division of Oral Health Sciences, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan.